137 related articles for article (PubMed ID: 9071985)
21. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
22. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
Krisch K; Krisch I; Horvat G; Neuhold N; Ulrich W
Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Lloyd RV; Sisson JC; Marangos PJ
Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
[TBL] [Abstract][Full Text] [Related]
24. Subtypes of thymic epithelial cells defined by neuroendocrine markers.
Brelińska R; Ostalska D; Zabel M
Histochem Cell Biol; 2000 Sep; 114(3):239-44. PubMed ID: 11083467
[TBL] [Abstract][Full Text] [Related]
25. Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.
Kovacs CS; Masé RM; Kovacs K; Nguyen GK; Chik CL
Cancer; 1994 Aug; 74(3):928-32. PubMed ID: 7913660
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
Deftos LJ; Linnoila RI; Carney DN; Burton DW; Leong SS; O'Connor DT; Murray SS; Gazdar AF
Cancer; 1988 Jul; 62(1):92-7. PubMed ID: 2838150
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical characterization of neuroendocrine tumours of the larynx.
Salim SA; Milroy C; Rode J; Corrin B; Hamid Q
Histopathology; 1993 Jul; 23(1):69-73. PubMed ID: 7690008
[TBL] [Abstract][Full Text] [Related]
28. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].
Schmid KW; Böcker W
Zentralbl Pathol; 1993 Jun; 139(2):115-29. PubMed ID: 8369268
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical alterations of C cells in sheep treated with vitamin D.
Okada H; Toyota N; Harimaya Y; Matsukawa K
J Comp Pathol; 1991 Oct; 105(3):263-70. PubMed ID: 1662236
[TBL] [Abstract][Full Text] [Related]
30. Hybridocytochemical and immuno-ultrastructural study of calcitonin gene expression in cultured medullary carcinoma cells.
Zabel M; Seidel J; Kaczmarek A; Surdyk-Zasada J; Grzeszkowiak J; Górny A
Histochemistry; 1994 Oct; 102(4):323-7. PubMed ID: 7843995
[TBL] [Abstract][Full Text] [Related]
31. Medullary carcinoma of the thyroid gland: an immunocytochemical study.
Holm R; Sobrinho-Simões M; Nesland JM; Gould VE; Johannessen JV
Ultrastruct Pathol; 1985; 8(1):25-41. PubMed ID: 3901454
[TBL] [Abstract][Full Text] [Related]
32. Oral granular cell tumours: a histological and immunocytochemical study.
Williams HK; Williams DM
J Oral Pathol Med; 1997 Apr; 26(4):164-9. PubMed ID: 9176790
[TBL] [Abstract][Full Text] [Related]
33. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin and chromogranin A localization in medullary carcinoma of the thyroid by immunoelectron microscopy.
Silver MM; Hearn SA; Lines LD; Troster M
J Histochem Cytochem; 1988 Aug; 36(8):1031-6. PubMed ID: 3392392
[TBL] [Abstract][Full Text] [Related]
35. Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases.
LaGuette J; Matias-Guiu X; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):748-53. PubMed ID: 9236830
[TBL] [Abstract][Full Text] [Related]
36. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
37. [Gastrointestinal hormone profile in medullary thyroid carcinoma].
Wirth HP; Eberle C; Meyenberger C; Bertschinger P; Häcki WH; Ammann R; Heitz PU
Schweiz Med Wochenschr; 1994 May; 124(21):906-11. PubMed ID: 8016606
[TBL] [Abstract][Full Text] [Related]
38. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
39. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
